Mice with systemic deficiency of Fpr2 demonstrate reduced severity of HFD-induced obesity, insulin resistance, hyperglycemia, hyperlipidemia, and hepatic steatosis (97). The gene discussed is FPR2; the disease is obesity due to melanocortin 4 receptor deficiency.